Learn more about how the Medicare Part D prescription payment structure changed in 2025 and how to maximize medication ...

Though he is a Republican, the policies enacted during Donald Trump's first few months in office directly contradict ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump ...

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.

The Most Favored Nation order is unlikely to deliver broad, sustained savings without triggering legal challenges, ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Tariffs are quietly driving up drug prices—here’s how it hurts you most *Pharmaceuticals represent a critical component of ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

Republicans’ “big, beautiful bill” appears on a glidepath to passing the House this morning after GOP leaders rolled out a ...

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...

From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led ...